Scientists have developed a blood test method for the early diagnosis of pancreatic cancer. With the success of this important research, this deadly and life threatening cancer can be detected at a treatable stage.
In this regard, scientists at the University of Pennsylvania in the United States have developed a new blood test that could potentially help in the early identification of pancreatic cancer and thus save thousands of lives.
This research report has been published in the medical journal AACR, in which different substances were tested in preserved blood samples of people with and without pancreatic cancer.
It is worth noting that millions of people suffer from pancreatic cancer every year. The reason is that its treatment is very difficult and its diagnosis requires great effort, due to which it is often detected very late, and by then treatment options become limited. Only 10 percent of patients survive more than five years after diagnosis, and more than half of patients die within three months.
However, it is now hoped that this new test will be able to identify pancreatic ductal adenocarcinoma in its early stages, which is the most common, aggressive, and deadly form of pancreatic cancer. This will give doctors time to treat patients and increase their chances of survival.
